- Presentations
- 2
- Markets
- 1
Cimerli is a brand of Ranibizumab marketed by Sandoz, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ranibizumab
- Brand owner
- Sandoz
- Registered in
- United States
- Strengths and forms
- 0.3 mg/0.05 mL injection, 0.5 mg/0.05 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Cimerli 0.3 mg/0.05 mL injectionIntravitreal Cold chain | Sandoz | US FDA | Available on request |
| Cimerli 0.5 mg/0.05 mL injectionIntravitreal Cold chain | Sandoz | US FDA | Available on request |
Equivalent brands
Other brands of Ranibizumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Cimerli
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.